Corona Virus Health Life Science medical

COVID-19 Continuation may cause brain inflammation other nerve disease : Researchers

According to a new study, published in the journal The Lancet Neurology , researchers from the University of Liverpool in the UK, COVID-19 has been associated mostly with problems like difficulty breathing, fever and cough. However, as the pandemic has continued, it has become increasingly clear that other problems can occur in patients. These include Read More…

Corona Virus Health Life Science medical

COVID-19 Is Airborne Writes Scientists Open Letter To WHO .. 2 / 2

In continuation of yesterday article 1/2  Many experts said the WHO should embrace what some called a “precautionary principle” and others called “needs and values”  the idea that even without definitive evidence, the agency should assume the worst of the virus, apply common sense and recommend the best protection possible. “There is no incontrovertible proof Read More…

Corona Virus Health Life Science medical World

COVID-19 is airborne writes Scientists Open Letter to WHO .. 1 / 2

What many scientists have been saying for months ever since the spread of Corona Virus is the virus lingers in the air indoors, infecting those nearby.   This has come true with the findings that coronavirus giving rise to frightening clusters of infection that increasingly attack new victims worldwide, in bars and restaurants, offices, markets Read More…

Corona Virus Health medical Voice

Worried with rapid rise of COVID-19 cases in India ICMR revises Guidelines

ICMR revised guidelines come against India’s rapid rising COVID-19 tally to 6,27,883 and ranked 4th highest in Global rank . As on date India under BJP party led Modi government stood 8th rank in Global death toll due to the disease rose to 18,311   With a large number of Indians testing positive for COVID-19 showing Read More…

Corona Virus Health medical

With in a year COVID-19 vaccine would emerge : WHO

Scientists predict the world may have a COVID-19 vaccine within one year or even a few months earlier, said the Director-General of the World Health Organisation even as he underlined the importance of global cooperation to develop, manufacture and distribute vaccines.   However, making the vaccine available and distributing it to all will be a Read More…

Companies Corona Virus Health Indian Subcontinent Industries Life Science medical

Cipremi : COVID-19 treatment drug from Cipla available by July 10

Pharma Company  Cipla Ltd is looking to make the generic version of US-based Gilead Sciences’ anti-viral drug remdesivir available in India in the next 8-10 days and price it less than ₹ 5,000 per vial Gilead Sciences extended a voluntary non-exclusive license to Cipla in May to manufacture and market Cipla’s generic version of remedisvir Read More…

Corona Virus Fact Check Health medical Voice

COVID-19 medicine : Patanjali warned by Ayush Ministry not to release Advertisements

Hours after yoga guru Ramdev came out with a “medicine” for Covid-19, the Centre has asked his Patanjali Ayurved Ltd to stop advertising or publicising its claims till the issue is “duly examined”. Taking cognizance of media reports, the Ayush Ministry said that “facts of the claim and details of the stated scientific study are Read More…

Corona Virus Health Life Science medical

FabiFlu apt for mild to moderate Covid-19 patients : Glenmark Pharma

Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate Covid-19 at a price of about Rs 103 per tablet. The Mumbai-based firm had on Friday received the manufacturing and marketing approval from the Drugs Controller General of Read More…

Corona Virus Health medical

Gilead injectable drug to treat hospitalised Covid-19 patients

Hyderabad-based Hetero will launch remdesivir, an injectable drug from Gilead, to treat hospitalised Covid-19 patients within this week. The company will first make the drug available in the main disease burden areas of Maharashtra and Delhi under the brand Covifor.   A single dose vial is likely to cost between Rs 5,000-6000, the company said. Read More…